China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $34.5M
Liabilities Breakdown FY2021
Total Liabilities: $18.6M
Asset Breakdown
Total Assets: $34.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $13.4M | 38.7% |
| Accounts Receivable | $4.5M | 13.0% |
| Inventory | $859.7K | 2.5% |
| Property, Plant & Equipment | $1.4M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $45.8K | 0.1% |
| Other Assets | $14.3M | 41.5% |
Liabilities Breakdown
Total Liabilities: $18.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 7.8% |
| Long-Term Debt | $6.3K | 0.0% |
| Other Liabilities | $17.1M | 92.1% |